Clinical trial
A Study to Compare Tenofovir Disoproxil Fumarate Versus Adefovir Dipivoxil for…
NCT00117676 · Gilead Sciences, Industry · Completed
Key facts
| NCT number | NCT00117676 |
|---|---|
| Title | A Study to Compare Tenofovir Disoproxil Fumarate Versus Adefovir Dipivoxil for the Treatment of HBeAg-Negative Chronic Hepatitis B |
| Official title | A Randomized, Double-Blind, Controlled Evaluation of Tenofovir DF Versus Adefovir Dipivoxil for the Treatment of Presumed Pre-Core Mutant Chronic Hepatitis B |
| Lead sponsor | Gilead Sciences, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Chronic Hepatitis B |
| Intervention type | Drug |
| Interventions | TDF, ADV, TDF placebo, ADV placebo, FTC/TDF |
| Enrollment | 382 |
| Start date | Feb 1, 2005 |
| Primary completion | Apr 1, 2007 |
| Completion | Jan 1, 2016 |
| First posted | Jul 8, 2005 |
| Last update posted | Mar 7, 2017 |
| Countries | Australia, Bulgaria, Canada, Czechia, France, Germany, Greece, Italy, Netherlands, New Zealand, Poland, Spain and 3 more |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: